RhumbLine Advisers
CYT

RhumbLine Advisers’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

RhumbLine Advisers’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,555
Closed -$47K – 3281
2022
Q1 		$47K Buy
+12,555
New +$47K ﹤0.01% 2978